Muscle Stimulator Market: Growth, Trends, and Key Insights
The global muscle stimulator market is witnessing steady growth as healthcare providers and consumers increasingly turn to electrical stimulation devices for pain management, rehabilitation, and muscle toning. Muscle stimulators are medical devices designed to treat impaired muscle function arising from conditions such as stroke, muscle injury, and major surgery. Beyond clinical rehabilitation, these devices are also used to prevent muscle atrophy, relieve chronic pain, treat muscle spasms, and strengthen core and abdominal muscles, making them relevant across both therapeutic and aesthetic use cases.
Market Size and Growth Trajectory
The global muscle stimulator market size was valued at USD 0.82 billion in 2025, according to Fortune Business Insight. The market is projected to grow from USD 0.85 billion in 2026 to USD 1.11 billion by 2034, exhibiting a compound annual growth rate (CAGR) of 3.36% during the forecast period, according to Fortune Business Insight. This steady, moderate growth trajectory reflects consistent demand from rehabilitation clinics, hospitals, and homecare settings, even as the market matures in several developed regions.
Key Drivers Fueling Market Growth
One of the predominant forces driving demand for muscle stimulators is the rising global burden of musculoskeletal disorders that limit patient mobility. According to data published by the World Health Organization in 2022 and cited by Fortune Business Insight, an estimated 1.71 billion people worldwide suffer from musculoskeletal disorders, with low back pain standing out as the leading cause of disability globally. Research has shown that devices such as transcutaneous electrical stimulators are effective in reducing pain intensity, which continues to push adoption among patients seeking non-invasive pain relief options.
A second major growth driver is the aesthetic and fitness segment. Manufacturers have increasingly launched advanced muscle stimulators aimed at toning, strengthening, and firming the body’s abdominal muscles, appealing to a growing base of consumers conscious of their physique and overall body shape. For instance, in December 2021, Cutera, Inc., a well-known player in energy-based aesthetic devices, launched truSculpt flex, a next-generation muscle sculpting device built on proprietary multi-directional stimulation technology that delivers toning and firming results in a fraction of the typical treatment time, according to Fortune Business Insight.
Impact of COVID-19 on the Market
The COVID-19 pandemic initially disrupted the muscle stimulator market, as supply chains were interrupted and patient visits to physiotherapy clinics declined sharply. However, the pandemic also revealed new clinical applications for these devices. According to a study published in NCBI in 2022 and referenced by Fortune Business Insight, rehabilitation using neuromuscular electrical stimulation (NMES) was shown to improve muscle functionality and strength in patients recovering from sepsis and septic shock associated with critical COVID-19 cases.
Further supporting this trend, Avazzia, Inc., in collaboration with Baylor College of Medicine, initiated a Phase I clinical trial in December 2020 to study the effectiveness of lower extremity electrical stimulation therapy in preventing muscular weakness and complications among COVID-19 patients, according to Fortune Business Insight. Regulatory bodies also responded quickly to the pandemic’s demands. In May 2020, Liberate Medical received emergency use authorization from the U.S. FDA for its VentFree Respiratory Muscle Stimulator, designed to reduce abdominal wall muscle atrophy in adult COVID-19 patients, according to Fortune Business Insight.
Market Segmentation Analysis
The muscle stimulator market is segmented by product type, including Functional Electrical Stimulators (FES), Neuromuscular Electrical Stimulators (NMES), Transcutaneous Electrical Nerve Stimulation (TENS) devices, and others. Among these, functional electrical stimulators accounted for a significant share of the market, according to Fortune Business Insight. This dominance is attributed to the rising prevalence of foot drop conditions linked to stroke, traumatic brain injury, multiple sclerosis, and other neurological disorders. The continued approval and commercial launch of FES devices by key manufacturers is expected to further propel this segment during the forecast period. A notable example is Bioness Inc., acquired by Bioventus, which commercially launched its L100 Go system in November 2020 to support patients suffering from foot drop associated with motor neuron disease or injury, according to Fortune Business Insight.
The market is also segmented by type (implantable and external devices), application (musculoskeletal disorders, pain management, neurological disorders, and others), and end user (hospitals, physiotherapy and rehabilitation clinics, homecare settings, and others).
Regional Landscape
North America is projected to hold the largest share of the muscle stimulator market and is expected to maintain this leading position throughout the forecast period, according to Fortune Business Insight. This dominance stems from a high prevalence of the target patient population, strong initiatives by key industry players, expanding product portfolios, and favorable reimbursement policies for these devices. In November 2022, MyndTec Inc. launched a new FES product called MyndStep, designed to address foot drop ailments, and entered into a distribution agreement with Guangzhou Longest Science & Technology Co. Ltd. to distribute the product across the U.S. and Canada, according to Fortune Business Insight.
Asia Pacific is projected to exhibit lucrative growth during the forecast period, driven by the rising prevalence of musculoskeletal disorders, traumatic brain injuries, and neurological conditions across the region, according to Fortune Business Insight. According to the Brain Foundation, one of Australia’s largest independent brain and spinal injury research funders, approximately 56,000 Australians experience strokes each year, a statistic cited by Fortune Business Insight to underscore regional demand. Improving healthcare infrastructure, including new clinics and hospitals, expanding awareness programs, and fresh product launches, are collectively fueling market growth across Asia Pacific. For example, in 2021, PhysioTattava, a chain of physiotherapy clinics, was founded in India to deliver pain management solutions through physiotherapy and other non-invasive treatment procedures, according to Fortune Business Insight.
Competitive Landscape
The muscle stimulator market features several established players working to strengthen their market position through product innovation and strategic collaborations. Key companies covered in the market include Bioventus, HASOMED GmbH, Omron Corporation, DJO, LLC, Zynex Medical, Restorative Therapies, Beurer GmbH, and PlayMakar, according to Fortune Business Insight. Recent industry developments highlight this competitive activity: in March 2022, Cionic received FDA clearance for its lightweight, leg-worn Cionic Neural Sleeve featuring functional electrical stimulation to address foot drop and leg muscle weakness. In December 2021, Sky Medical Technology Ltd. secured FDA approval for its geko neuromuscular electrical stimulator device, intended to improve microcirculatory blood flow in patients with venous insufficiency or ischemia. Additionally, in June 2021, Medline Industries, LP entered into an exclusive collaboration with Spectramed to optimize treatment for patients suffering from dysphagia, according to Fortune Business Insight.
Conclusion
The muscle stimulator market is set for continued, steady expansion through 2034, supported by rising musculoskeletal and neurological disorder prevalence, innovative product launches spanning clinical and aesthetic applications, and improving healthcare infrastructure in emerging regions. As manufacturers continue to invest in advanced, user-friendly devices, the market is well-positioned to serve both therapeutic rehabilitation needs and the growing consumer interest in non-invasive body toning solutions.
What’s Driving Japan’s Market? Discover the Latest “Muscle Stimulator” Insights
https://www.fortunebusinessinsights.com/jp/muscle-stimulator-market-107858